Article info
Public health ethics
Paper
Is risk stratification ever the same as ‘profiling’?
- Correspondence to Dr R Scott Braithwaite, Department of Population Health, New York University School of Medicine, 227 E 30th St, Room 615, New York NY 10016, USA; scott.braithwaite{at}nyumc.org
Citation
Is risk stratification ever the same as ‘profiling’?
Publication history
- Received July 28, 2015
- Revised December 2, 2015
- Accepted January 4, 2016
- First published January 21, 2016.
Online issue publication
April 25, 2016
Article Versions
- Previous version (21 January 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Risk assessment and stratification of mild cognitive impairment among the Chinese elderly: attention to modifiable risk factors
- Prevention of sudden cardiac death in hypertrophic cardiomyopathy
- A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
- Is health profiling morally permissible?
- Which strings attached: ethical considerations for selecting appropriate conditionalities in conditional cash transfer programmes
- Risk factors, risk stratification and risk-specific surveillance strategies after endovascular aneurysm repair: study protocol for a Delphi study by the International RIsk Stratification in EVAR (IRIS-EVAR) working group
- Commercial surrogacy: how provisions of monetary remuneration and powers of international law can prevent exploitation of gestational surrogates
- Fair and equitable subject selection in concurrent COVID-19 clinical trials
- Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
- Methods and principles in biomedical ethics